Four scientist in a laboratory discussing the work

A new frontier
in drug formulation

The Dispersome®️ technology allows formulation of poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.

Dispersome®️ - An enabling technology for low solubility drugs

DISPERSOME®️ PLATFORM

Our Dispersome®️ platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.

IMPROVING OUTCOMES

By increasing solubility and dissolution rate the Dispersome®️ platform aims at improving bioavailability, therapeutic outcomes and convenience for patients.

COMPATIBLE TECHNOLOGY

Dispersome®️ formulations are compatible with standard solid oral dosage form manufacturing processes and facilities.

Five white tablets in a blue background

About Zerion Pharma

Zerion is a pharmaceutical development company improving the formulation of poorly soluble drugs (oral solid dosage forms) that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, Dispersome®️, we aim to develop new treatment options for patients across all therapeutic areas.

Learn more

Our technology

Up to 90 % of all new drug molecules are poorly soluble, which can be a problem as the drug must dissolve in order to be absorbed and reach its pharmacological target.

Learn more

Zerion Pharma News

Press Releases
|
May 10, 2021

ZERION PHARMA elects Dr. Torsten Goesch and Dr. Lars Lykke Thomsen as new board members

(Copenhagen, May 10, 2021). ZERION Pharma, a Danish pharmaceutical company, elected two new members Dr. Torsten Goesch and Dr. Lars Lykke Thomsen to join its board of directors at the annual general meeting held...

____________________
Zerion Team
|
April 8, 2021

Zerion Team in Numbers

An international and very diverse team is behind Zerion Pharma – a drug development company improving the formulation of poorly soluble drugs that are currently not reaching their therapeutical potential...

____________________
Zerion Team
|
March 12, 2021

ZERION Pharma expands its team with a Communications Specialist and a Formulation Technician

Ieva Jasiukenaite is joining ZERION’s commercial team as a Communications Specialist and Camila Belavi is joining ZERION’s R&D team as a Laboratory Technician. Both already joined ZERION during February and March...

____________________
More news

Zerion Pharma in Press